Mavacamten for symptomatic obstructive hypertrophic cardiomyopathy. [PDF]
europepmc +1 more source
Phenotype-Based Classification of Obstructive Hypertrophic Cardiomyopathy Undergoing Myectomy. [PDF]
Cui H +15 more
europepmc +1 more source
Health Care Resource Use and Economic Burden in Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy and Atrial Fibrillation. [PDF]
Stendahl JC +7 more
europepmc +1 more source
Feline hypertrophic cardiomyopathy – prevalence, risk factors and pathological aspect [PDF]
Khor, Kuan Hua
core
Efficacy of aficamten in obstructive hypertrophic cardiomyopathy: A systematic review and meta-analysis. [PDF]
Saddique MN +14 more
europepmc +1 more source
A plain language summary of the SEQUOIA-HCM study: aficamten for symptomatic obstructive hypertrophic cardiomyopathy. [PDF]
Maron MS, Olivotto I, van Sinttruije M.
europepmc +1 more source
Adolescent with severe obstructive hypertrophic cardiomyopathy. [PDF]
Ramineni A +7 more
europepmc +1 more source
Chemical myectomy with mavacamten in patients with obstructive hypertrophic cardiomyopathy with prior septal reduction therapy: A single-center experience. [PDF]
Hundal P +7 more
europepmc +1 more source

